These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 12604436)

  • 1. Your heart attack risk: inflammation counts. A woman with normal cholesterol levels can still be at high risk for a heart attack. Should she have a test to find out?
    Harv Womens Health Watch; 2003 Feb; 10(6):1-3. PubMed ID: 12604436
    [No Abstract]   [Full Text] [Related]  

  • 2. Beyond cholesterol: a new clue to heart disease.
    Johns Hopkins Med Lett Health After 50; 2003 Mar; 15(1):4-5. PubMed ID: 12703447
    [No Abstract]   [Full Text] [Related]  

  • 3. Exercise, C-reactive protein, and your heart.
    Harv Mens Health Watch; 2005 Jul; 9(12):1-4. PubMed ID: 16161240
    [No Abstract]   [Full Text] [Related]  

  • 4. Inflammation, atherosclerosis, and stroke.
    Elkind MS
    Neurologist; 2006 May; 12(3):140-8. PubMed ID: 16688015
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Serum lipid profiles and homocysteine levels in adults with stroke or myocardial infarction in the town of Gombe in northern Nigeria.
    Glew RH; Okolie H; Crossey M; Suberu O; Trujillo M; Pereyra M; Vanderjagt DJ
    J Health Popul Nutr; 2004 Dec; 22(4):341-7. PubMed ID: 15663167
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Coronary artery disease prognosis and C-reactive protein levels improve in proportion to percent lowering of low-density lipoprotein.
    O'Keefe JH; Cordain L; Jones PG; Abuissa H
    Am J Cardiol; 2006 Jul; 98(1):135-9. PubMed ID: 16784936
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Jupiter study, CRP screening, and aggressive statin therapy-implications for the primary prevention of cardiovascular disease.
    Kones R
    Ther Adv Cardiovasc Dis; 2009 Aug; 3(4):309-15. PubMed ID: 19460829
    [TBL] [Abstract][Full Text] [Related]  

  • 8. New test may help determine atherosclerosis risk.
    Harv Heart Lett; 2001 Oct; 12(2):1-2. PubMed ID: 11684486
    [No Abstract]   [Full Text] [Related]  

  • 9. Should you see about your CRP? A simple blood test for C-reactive protein is joining cholesterol screening as an early warning for heart disease. But not everyone needs it.
    Harv Heart Lett; 2003 Mar; 13(7):3-4. PubMed ID: 12654581
    [No Abstract]   [Full Text] [Related]  

  • 10. Relation of clinical benefit of raising high-density lipoprotein cholesterol to serum levels of low-density lipoprotein cholesterol in patients with coronary heart disease (from the Bezafibrate Infarction Prevention Trial).
    Goldenberg I; Benderly M; Sidi R; Boyko V; Tenenbaum A; Tanne D; Behar S
    Am J Cardiol; 2009 Jan; 103(1):41-5. PubMed ID: 19101227
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Clinical evaluation of arteriosclerosis using high sensitive CRP in multiphasic screening].
    Tonari Y; Koyama T; Saitoh K
    Rinsho Byori; 2004 Aug; 52(8):637-41. PubMed ID: 15478618
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Usefulness of preoperative C-reactive protein and soluble intercellular adhesion molecule-1 level for predicting future cardiovascular events after coronary artery bypass grafting.
    van der Harst P; Voors AA; Volbeda M; Buikema H; van Veldhuisen DJ; van Gilst WH
    Am J Cardiol; 2006 Jun; 97(12):1697-701. PubMed ID: 16765116
    [TBL] [Abstract][Full Text] [Related]  

  • 13. C-reactive protein, interleukin-6, and fibrinogen as predictors of coronary heart disease: the PRIME Study.
    Luc G; Bard JM; Juhan-Vague I; Ferrieres J; Evans A; Amouyel P; Arveiler D; Fruchart JC; Ducimetiere P;
    Arterioscler Thromb Vasc Biol; 2003 Jul; 23(7):1255-61. PubMed ID: 12775578
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Older age and markers of inflammation are strong predictors of clinical events in women with asymptomatic carotid lesions.
    Corrado E; Rizzo M; Muratori I; Coppola G; Novo S
    Menopause; 2008; 15(2):240-7. PubMed ID: 17917609
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Lipid metabolism and risk of myocardial infarction -- new findings and implications for treatment].
    Cullen P; Schulte H; Assmann G
    Dtsch Med Wochenschr; 2005 Sep; 130(39):2220-5. PubMed ID: 16189760
    [No Abstract]   [Full Text] [Related]  

  • 16. Prediction of myocardial infarction by N-terminal-pro-B-type natriuretic peptide, C-reactive protein, and renin in subjects with cerebrovascular disease.
    Campbell DJ; Woodward M; Chalmers JP; Colman SA; Jenkins AJ; Kemp BE; Neal BC; Patel A; MacMahon SW
    Circulation; 2005 Jul; 112(1):110-6. PubMed ID: 15983245
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [The importance of non-lipid risk factors: a review focusing on C-reactive protein].
    Yilmaz Y; Ongen Z
    Turk Kardiyol Dern Ars; 2009 Apr; 37 Suppl 4():7-13. PubMed ID: 19553756
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Marked for heart trouble?
    Health News; 2000 Apr; 6(4):7. PubMed ID: 15356891
    [No Abstract]   [Full Text] [Related]  

  • 19. Rationale for targeted rather than population based screening with C-reactive protein using the National Health and Nutrition Examination Survey (1999 to 2002).
    Guttormsen BN; Stein JH; McBride PE; Cullen MW; Gangnon R; Keevil JG
    Am J Cardiol; 2007 Oct; 100(7):1130-3. PubMed ID: 17884376
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Usefulness of combined high-sensitive C-reactive protein and N-terminal-probrain natriuretic peptide for predicting cardiovascular events in patients with suspected coronary artery disease.
    Huang PH; Lu TM; Wu TC; Lin FY; Chen YH; Chen JW; Lin SJ
    Coron Artery Dis; 2008 May; 19(3):187-93. PubMed ID: 18418236
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.